The Recall Desk
ModerateFDA (Drugs)·D-0552-2026·Announced 2026-06-10

Eugia lidocaine vial label wrap covers the barcode

Eugia Lidocaine HCl Injection, USP 2% single-dose vials are being recalled because the label wrap covers the barcode, making it hard to scan. 168,300 vials are affected.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class III recall for a labeling defect that impedes barcode scanning, which the rubric places in the 1-2 band; it affects a verification step rather than being purely cosmetic.

Plain-English summary

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), in 2 mL single-dose vials, manufactured in India for Eugia US LLC of East Windsor, New Jersey, NDC 55150-164-02, is being recalled. The action covers 168,300 vials.

The stated reason is a labeling issue: the label wrap covers the barcode, making it hard to scan. The FDA classified the action as Class III, its least serious classification, which is applied where use of the product is not likely to cause adverse health consequences. The source does not describe any defect in the solution itself.

Affected lots are 3LC26029A (expiry February 2029) and 3LC26031A (expiry March 2029). Distribution was US nationwide.

This is a prescription product supplied to healthcare facilities. Facilities should check stock against the lot numbers above and follow the instructions issued by Eugia.

The recalled product

Product
LIDOLOG KIT (LIDOCAINE, KENALOG, POVIDONE IODINE)
Brand
LIDOLOG KIT
Manufacturer
Eugia US LLC
Hazard
  • labeling-error
  • obscured-barcode
  • class-iii
  • prescription-drug

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Lot
  • expiry: Lot 3LC26029A
  • exp Feb-2029
  • Lot 3LC26031A
  • exp Mar-2029

Distribution

Distributed nationwide across the United States.